– Immunodominant antibody germlines in COVID-19. J Exp Med 2021;218(5):e20210281.
– High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China. Front. Immunol., 2021; https://doi.org/10.3389/fimmu.2021.627844.
– Maturation and persistence of the anti-SARS-CoV-2 memory B cell response. Cell 2021;184(5):1201-1213.e14.
– IL-1 Receptor Antagonist Anakinra in the Treatment of COVID-19 Acute Respiratory Distress Syndrome: A Retrospective, Observational Study. J Immunol April 1, 2021;206(7):1569-1575.
– Lasting memories of SARS-CoV-2 infection. J Exp Med 2021;218(4):e20210210.
– What scientists do and don’t know about the Oxford–AstraZeneca COVID vaccine. Nature 2021; doi: https://doi.org/10.1038/d41586-021-00785-7.
– Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science 2021;371(6529):eabf4063.
En la sección: COVID-19, Infectología, Inmunoterapia, Vacunología. Publicado en: .